uploads///dna _

Analysts’ Ratings for Sorrento and Its Peers in March 2018

By

Mar. 29 2018, Updated 3:17 p.m. ET

Company overview

Sorrento Therapeutics (SRNE) is a clinical-stage biotechnology company. Its research programs are targeted at autoimmune, inflammatory, and neurodegenerative diseases and pain indications.

Essentially, Sorrento Therapeutics is an antibody-centric company and leverages its G-MAB library to generate product candidates. Its antibodies include PD-1, PD-L1, CD38, CD123, CD47, c-MET, VEGFR2, CCR2, OX40, TIGIT, and CD137.

Article continues below advertisement

Analysts’ recommendations

Of the two analysts covering Sorrento Therapeutics in March 2018, one analyst has given it a “strong buy” recommendation, and one has given it a “buy” recommendation. The mean rating for the stock is 1.5, and its target price is $24.5.

Peers’ ratings

Of the 23 analysts covering AbbVie (ABBV) in March 2018, four analysts have given the stock “strong buy” ratings, and six have given it “buy” ratings. Twelve analysts have given AbbVie “hold” ratings, while one has given it a “sell” rating. The mean rating for the stock is 2.43, and its target price is $125.9.

Of the eight analysts covering Novavax (NVAX) in March 2018, two have given the stock “strong buy” ratings, and one has given it a “buy” rating. Four analysts have given Novavax “hold” ratings, while one has given it a “sell” rating. The mean rating for the stock is 2.5, and its target price is $3.83.

Of the five analysts covering Arrowhead Pharmaceuticals (ARWR) in March 2018, one analyst has given the stock a “strong buy” rating, two analysts have given it “buy” ratings, and two have given it “hold” ratings. The mean rating for the stock is 2.2 with a target price of $5.5.

In the next part of this series, we’ll take a look at Sorrento Therapeutics’ research pipeline.

Advertisement

More From Market Realist

  • CONNECT with Market Realist
  • Link to Facebook
  • Link to Twitter
  • Link to Instagram
  • Link to Email Subscribe
Market Realist Logo
Do Not Sell My Personal Information

© Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.